TCL Archive “Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.” July 14, 1995
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
